Robinson v. Dr. Castleman

CourtDistrict Court, D. Nebraska
DecidedJuly 17, 2025
Docket8:23-cv-00451
StatusUnknown

This text of Robinson v. Dr. Castleman (Robinson v. Dr. Castleman) is published on Counsel Stack Legal Research, covering District Court, D. Nebraska primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Robinson v. Dr. Castleman, (D. Neb. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEBRASKA

KIRK D. ROBINSON,

Plaintiff, 8:23CV451

vs. MEMORANDUM AND ORDER DR. CASTLEMAN, DR. BRANK, and BRYAN HEALTH SYSTEMS,

Defendants.

This matter is before the Court on Plaintiff Kirk D. Robinson’s complaint filed on October 16, 2023. Filing No. 1. Plaintiff filed five supplements, Filing Nos. 6, 8, 9, 13 & 14, all of which have been deemed incorporated into the initial complaint and considered as part of this initial review. When the complaint was filed, Plaintiff was incarcerated within the Reception and Treatment Center (RTC) of the Nebraska Department of Correctional Services (NDCS). He remains incarcerated but is now confined at NDCS’ Tecumseh State Correctional Institution. Filing No. 16. The Court now conducts an initial review of Plaintiff’s claims to determine whether summary dismissal is appropriate under 28 U.S.C. § 1915(e)(2)(B). I. SUMMARY OF COMPLAINT Plaintiff sued Dr. Castleman, Dr. Brank, and Bryan Health Systems (BHS), all in their individual capacities. Filing No. 1 at 2-3, 12. The following summarizes his allegations. On May 26, 2023, Plaintiff awoke with severe pain in his left lower leg. Filing No. 1 at 14. He was transported to Bryan West Hospital in Lincoln, Nebraska, and was diagnosed with having a deep vein thrombosis (DVT) extending the entire length of his lower left leg. Filing No. 1 at 14. The following day, May 27, 2023, an EKG was performed on Plaintiff at the RTC. The EKG revealed atrial fibrillation (A-Fib). NDCS immediately returned Plaintiff to Bryan West Hospital. A CT scan was performed which revealed that in addition to the DVT in the lower leg, Plaintiff had dual pulmonary emboli. The Bryan West doctor stated Plaintiff was lucky to be alive. Filing No. 1 at 14; see also Filing No. 14 at 3. Dr. Brank and/or Bryan West Hospital prescribed a blood thinner, Eliquis, to be taken daily. No other treatment was provided or scheduled at that time. On June 13, 2023, Plaintiff had severe left leg pain and was again transported to Bryan West Hospital. A CT scan and MRI were performed. Plaintiff’s pulmonary emboli had not improved. The emergency room doctor diagnosed a “tweaked muscle” in the left leg, indicating he believed Plaintiff’s lower leg pain was (and perhaps had always been) muscle-related. Filing No. 1 at 15. Plaintiff complained of leg pain on August 3, 2023, and he was seen by the RTC medical staff. At that appointment, he was “encouraged several times to take his prescribed Eliquis.” Filing No. 13 at 3. On August 7, 2023, Plaintiff was transported to Bryan East Hospital for a consultation appointment. The APRN said cardioversion would be performed to address Plaintiff’s atrial fibrillation provided Plaintiff was compliant with taking his Eliquis for 30 days. Plaintiff missed a dose on August 17, 2023. Filing No. 1 at 18. Plaintiff saw Dr. Brank on September 28, 2023. The left leg remained swollen and sore. The doctor’s records state Plaintiff was compliant with taking his Eliquis, and he wanted prompt treatment of his atrial fibrillation. Dr. Brank said he would contact cardiology and schedule a cardioversion appointment. Filing No. 13 at 5. Plaintiff did not take his prescribed Eliquis the following two days, September 29 and 30. Filing No. 1 at 18. As of October 3, 2023, Plaintiff had heard nothing about scheduling the cardioversion. He sent an inmate interview request (IIR) complaining that the procedure had not been scheduled. Filing No. 1 at 18. On October 5, 2023, NDCS responded, explaining the cardioversion was not scheduled because Plaintiff had not taken his Eliquis on August 17, September 29 and 30, and October 4. Plaintiff was again instructed to take the medication for 30 consecutive days, and warned that if any doses were missed, the cardioversion could not be performed or even scheduled. Filing No. 1 at 15, 18. Plaintiff filed an emergency grievance on October 7, 2023, stating he had missed only four doses of the medication over a two-month period, was seen by Dr. Brank a week ago and his laboratory results were normal, and cannot exercise until his atrial fibrillation is treated. Filing No. 1 at 19. The emergency grievance was rejected because Plaintiff was not facing an immediate risk of harm. Plaintiff then decided he would stop taking Eliquis since the NDCS had apparently decided “it can make me suffer from one medical condition if the other one is taken care of.” Filing No. 6 at 1. In his IIR dated October 8, 2023, Plaintiff wrote, “I am not going to take the Eliquis any longer. . . . Let’s get the A-Fib fixed first, then take care of the blood clotting problem.” Filing No. 6 at 3. NDCS responded on October 13, 2023, advising Plaintiff that the prison scheduling person was contacted to set up a cardiology appointment. Plaintiff was reminded to take his medication, explaining “[i]f you stop taking the Eliquis, they won’t do the cardioversion. I would recommend continuing to take it regularly.” Filing No. 6 at 2. It is not safe to do a cardioversion unless you are taking the Eliquis. As far as I know, you are in the process of getting scheduled to see cardiology again.

In the meantime, you should take the Eliquis both for your safety and so that the procedure can be done.

Filing No. 6 at 3. In response to this instruction, Plaintiff’s next IRR stated, “I will not take the Eliquis until my A-Fib is fixed.” Filing No. 6 at 4. NDCS responded that, according to the cardiologist, Eliquis must be taken for 30 days both before and after the cardioversion, and it warned Plaintiff that failing to take the medication would delay the procedure and may cause a stroke. Filing No. 6 at 4. On October 27, 2023, NDCS notified Plaintiff that a cardiology appointment was scheduled to be held in a few weeks, reminded him that the cardioversion treatment would not be done if he was not consistently taking the prescribed Eliquis, and advised Plaintiff to take the medication if he still wanted the treatment. Filing No. 8 at 2. In his court filing dated November 6, 2023, Plaintiff wrote, “The only way I’ll take the blood thinning medication is if I’m in the hospital getting prepared for the cardioversion treatment for A- Fib.” Filing No. 8 at 1. Plaintiff submitted an IIR on November 2, 2023, reiterating his refusal to take Eliquis until he was hospitalized for his cardioversion procedure. Plaintiff further complained of left leg swelling, coughing and a buildup of fluid, and terrible headaches. Filing No. 9 at 2. On November 7, 2023, NDCS responded: Blood thinner helps prevent clot[s] that may form while you are in a-fib.

If you are cardioverted or return to normal rhythm while there is a clot in your heart, that clot could go to your brain & cause a stroke. It is important to take the blood thinner as prescribed for as long as cardiology wants you to take it prior to return to normal rhythm.

You have an upcoming appointment with cardio to discuss. Filing No. 9 at 2. Plaintiff alleges he needs cardioversion for treatment of atrial fibrillation, but the defendants have violated his Eighth Amendment rights by refusing to provide that treatment. Plaintiff states he has repeatedly advised Dr. Brank, a physician who works at the RTC, that his A-Fib prevents him from living a better quality of life. But Dr. Brank refuses to provide proper care to Plaintiff and has lied to Plaintiff about the care NDCS will provide. Filing No. 1 at 13. Plaintiff claims the NDCS Medical Director, Dr. Castleman, has adopted a NDCS policy for providing medical care to inmates which includes a formulary list of medications and medical procedures authorized for inmate care at NDCS’ expense.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Lugar v. Edmondson Oil Co.
457 U.S. 922 (Supreme Court, 1982)
Wilson v. Seiter
501 U.S. 294 (Supreme Court, 1991)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Langford v. Norris
614 F.3d 445 (Eighth Circuit, 2010)
Martin v. Aubuchon
623 F.2d 1282 (Eighth Circuit, 1980)
Holden v. Hirner
663 F.3d 336 (Eighth Circuit, 2011)
Gibson v. Weber
433 F.3d 642 (Eighth Circuit, 2006)
Hughes v. Stottlemyre
454 F.3d 791 (Eighth Circuit, 2006)
Grayson v. Ross
454 F.3d 802 (Eighth Circuit, 2006)
Brockinton v. City of Sherwood
503 F.3d 667 (Eighth Circuit, 2007)
Rodriguez v. Plymouth Ambulance Service
577 F.3d 816 (Seventh Circuit, 2009)
Robin Magee v. Trustees of Hamline University
747 F.3d 532 (Eighth Circuit, 2014)
Samvel Topchian v. JPMorgan Chase Bank, N.A.
760 F.3d 843 (Eighth Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Robinson v. Dr. Castleman, Counsel Stack Legal Research, https://law.counselstack.com/opinion/robinson-v-dr-castleman-ned-2025.